Diagnostic based on 8 periods of real financial statements. Three priority levers with quantified impact on NOPAT and invested capital.
ROIC decomposes into two drivers whose product equals total return. Each diagnostic lever moves one of them.
Not all levers execute the same way. This matrix prioritizes along two dimensions: how much it moves ROIC and how quickly value is captured. Bubbles in the upper left are first-wave implementations; those on the right require longer organizational transformation.
SG&A: $116B (20.8% revenue)
EBITDA margin: 6.0%
vs 7.4% in Year 1
Efficient retail: 18-19% SG&A
Target EBITDA: 8-9%
Gap: ~2pp margin
Overhead audit by function
Target: -2pp SG&A in 18 months
Value: +$7.6B NOPAT
Avg capex: $32B/year
No minimum ROIC criteria
LTD grew $27B in 4 years
Efficient retail: 3-4% revenue
Minimum required ROIC: 12%
Industry standard hurdle rate
Set 12% ROIC hurdle rate
Freeze uncommitted capex
Value: +$6.8B freed/year
Year 7 inventory: $65B
Historical Years 1-6: $45-48B
Inventory days: ~58 days
Target inventory days: 35-40
Own historical level: $46B
Gap: $17-20B in capital
Selective liquidation program
Target: $48B in 12 months
Value: +$8.7B capital freed
Figures in USD millions. Basis of the analysis above.
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 | Year 8 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 485,651 | 482,130 | 485,873 | 500,343 | 514,405 | 523,964 | 559,151 | 572,754 |
| COGS | (355,913) | (351,530) | (351,176) | (362,867) | (374,623) | (383,618) | (409,163) | (418,342) |
| Gross Profit | 129,738 | 130,600 | 134,697 | 137,476 | 139,782 | 140,346 | 149,988 | 154,412 |
| SG&A | (93,418) | (97,041) | (101,853) | (106,510) | (107,147) | (108,791) | (116,288) | (117,812) |
| EBITDA | 35,869 | 33,173 | 32,194 | 27,169 | 23,758 | 33,193 | 33,714 | 30,923 |
| Depreciation | (9,173) | (9,454) | (10,080) | (10,529) | (10,678) | (10,987) | (11,152) | (10,658) |
| EBIT | 26,696 | 23,719 | 22,114 | 16,640 | 13,080 | 22,206 | 22,562 | 20,265 |
| Interest Expense | (2,461) | (2,548) | (2,367) | (2,330) | (2,346) | (2,599) | (2,315) | (1,994) |
| Interest Income | 113 | 81 | 100 | 152 | 217 | 189 | 121 | 158 |
| EBT | 24,348 | 21,252 | 19,847 | 14,462 | 10,951 | 19,796 | 20,368 | 18,429 |
| Provision for Taxes | (7,985) | (6,558) | (6,204) | (4,600) | (4,281) | (4,915) | (6,858) | (4,756) |
| Net Income | 16,363 | 14,694 | 13,643 | 9,862 | 6,670 | 14,881 | 13,510 | 13,673 |
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 | Year 8 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating | ||||||||
| Net Income | 16,363 | 14,694 | 13,643 | 9,862 | 6,670 | 14,881 | 13,510 | 13,673 |
| Depreciation | 9,173 | 9,454 | 10,080 | 10,529 | 10,678 | 10,987 | 11,152 | 10,658 |
| Cash From Accounts Receivable | (6,778) | 1,154 | (211) | 221 | (669) | (1) | (232) | (1,764) |
| Cash From Inventory | (47,365) | 1,455 | 923 | (2,307) | (598) | 1,835 | (19,753) | 7,780 |
| Cash From Accounts Payable | 58,583 | 32 | 4,393 | 5,851 | 788 | (98) | 17,800 | (5,177) |
| Subtotal | 29,976 | 26,789 | 28,828 | 24,156 | 16,869 | 27,604 | 22,477 | 25,170 |
| Cash from Investing | ||||||||
| Capital Expenditure | (10,414) | (19,850) | (24,915) | (24,309) | (35,829) | (41,264) | (6,593) | (24,598) |
| Subtotal | (10,414) | (19,850) | (24,915) | (24,309) | (35,829) | (41,264) | (6,593) | (24,598) |
| Cash from Financing | ||||||||
| Change in Long-Term Debt | (5,018) | (2,624) | (317) | (5,967) | 21,190 | 14,714 | (5,110) | (4,698) |
| Change in Common Equity | (10,053) | (663) | 554 | 267 | 310 | 278 | 397 | 1,187 |
| Dividends | — | — | — | — | — | — | — | — |
| Change in Revolving Credit Line | — | (685) | (2,084) | 5,742 | (1,832) | 411 | (2,945) | (89) |
| Subtotal | (15,071) | (3,972) | (1,847) | 42 | 19,668 | 15,403 | (7,658) | (3,600) |
| Cash Balance | ||||||||
| Beginning of the Year | 4,644 | 5,738 | 4,801 | 6,867 | 7,014 | 7,722 | 9,515 | 17,788 |
| Increase / (Decrease) | 4,491 | 2,967 | 2,066 | (111) | 708 | 1,743 | 8,226 | (3,028) |
| End of the Year | 9,135 | 8,705 | 6,867 | 6,756 | 7,722 | 9,465 | 17,741 | 14,760 |
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 | Year 8 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash | 9,135 | 8,705 | 6,867 | 6,756 | 7,722 | 9,465 | 17,741 | 14,760 |
| Accounts Receivable | 6,778 | 5,624 | 5,835 | 5,614 | 6,283 | 6,284 | 6,516 | 8,280 |
| Inventories | 47,365 | 45,910 | 44,987 | 47,294 | 47,892 | 46,057 | 65,810 | 58,030 |
| Total Current Assets | 63,278 | 60,239 | 57,689 | 59,664 | 61,897 | 61,806 | 90,067 | 81,070 |
| Property Plant & Equipment | 140,428 | 139,342 | 141,136 | 144,858 | 157,398 | 174,689 | 162,429 | 163,790 |
| Total Assets | 203,706 | 199,581 | 198,825 | 204,522 | 219,295 | 236,495 | 252,496 | 244,860 |
| Liabilities | ||||||||
| Accounts Payable | 58,583 | 58,615 | 63,008 | 68,859 | 69,647 | 69,549 | 87,349 | 82,172 |
| Revolving Credit Line | 6,689 | 6,004 | 3,920 | 9,662 | 7,830 | 8,241 | 5,296 | 5,207 |
| Total Current Liabilities | 65,272 | 64,619 | 66,928 | 78,521 | 77,477 | 77,790 | 92,645 | 87,379 |
| Long-Term Debt | 57,040 | 54,416 | 54,099 | 48,132 | 69,322 | 84,036 | 78,926 | 74,228 |
| Total Liabilities | 122,312 | 119,035 | 121,027 | 126,653 | 146,799 | 161,826 | 171,571 | 161,607 |
| Equity | ||||||||
| Common Equity | 2,785 | 2,122 | 2,676 | 2,943 | 3,253 | 3,531 | 3,928 | 5,115 |
| Retained Earnings | 78,609 | 78,424 | 75,122 | 74,926 | 69,243 | 71,138 | 76,997 | 78,138 |
| Total Shareholders' Equity | 81,394 | 80,546 | 77,798 | 77,869 | 72,496 | 74,669 | 80,925 | 83,253 |
| Total Liabilities & Equity | 203,706 | 199,581 | 198,825 | 204,522 | 219,295 | 236,495 | 252,496 | 244,860 |